
ValuationHealthcare & Life Sciences
Temple valuation: $375M
Temple doubles valuation to $375M in secondary sale
By Abha Lohia · Editor ·
Temple valuation
Temple was valued at $375M (2026), as reported by inc42, Indian Startup News and indian-startup-times on 27 July 2026.
| Valuation (2026) | $375M |
|---|
Temple: valuation and funding and every story →
seedFounded 2025
- Temple makes a forehead-worn wearable that tracks the body's metabolic state in real time
- The company completed a secondary share sale at a $375M valuation, nearly double its seed round valuation of $190M
- The deal included an ESOP buyback for about 20 employees, allowing them to sell up to 25% of vested options
What happened
- Temple completed a secondary share sale at a $375M valuation, nearly double its previous $190M valuation.
- The company also launched its first ESOP liquidity programme, allowing about 20 employees (out of 200-220 total) to sell up to 25% of vested ESOPs.
- The ESOP buyback was done at the $375M valuation and was optional for eligible employees.
- Founder Deepinder Goyal told employees that external investor interest exists at a ~$500M valuation for the next round, but the buyback was done at $375M to let employees benefit before the next raise.
- Temple declined to comment on queries about the transaction.
- The company is associated with Goyal's longevity research initiative Continue Research.
- Nine startups have completed ESOP buybacks worth over $270M in 2026 so far.
Why it matters
- The secondary sale nearly doubles Temple's valuation from its seed round in February 2026.
- The ESOP buyback is the first for the company and signals confidence in its growth.
- The transaction comes amid a broader trend of Indian startups offering liquidity to employees, with nine companies completing buybacks worth over $270M in 2026.
The business
- Temple is developing a forehead-worn wearable that measures the body's metabolic state in real time.
- The device tracks a metric called 'Entropy', which represents metabolic and sympathetic demands on the body.
- The product is currently in an early access programme, with a commercial launch expected within the next year, subject to validation.
- Manufacturing partners include Ethereal Machines and Zetwerk.
- The company has 200-220 employees and an ESOP pool of 10% of share capital.
- Temple is associated with Deepinder Goyal's longevity research initiative Continue Research.
- Continue Research published a hypothesis that reduced cerebral blood flow from gravity may be an overlooked aging factor, but Goyal said the wearable could succeed even if the hypothesis is wrong.
The founders
- Stepped down as group CEO of Eternal (Zomato, Blinkit) effective 1 February 2026.
- Remains vice-chairman of Eternal.
- Owns approximately 28% of Temple (28.6% per filings after the seed round).
Who put in money
- Steadview Capital existing — Expected to hold ~5.3% stake after seed round.
- Peak XV Partners existing — Expected to hold ~3.2% stake after seed round.
- Vy Capital existing — Participated in seed round.
- Info Edge existing — Participated in seed round.
- Dharana Capital existing — Participated in seed round.
- NKSquared existing — Family office of Zerodha co-founder Nikhil Kamath, participated in seed round.
In numbers
$375MValuation (secondary sale) · 2026
$190MValuation (seed round) · 2026
$54MSeed round amount · 2026
200-220Employees · 2026
10% of share capitalESOP pool · 2026
~20Employees eligible for ESOP buyback · 2026
25% of vested ESOPsMaximum ESOP sellable per employee · 2026
~28%Founder stake · 2026
~5.3%Steadview Capital stake (post seed) · 2026
~3.2%Peak XV Partners stake (post seed) · 2026
What happens next
- Commercial launch expected within the next year, subject to validation.
- Next funding round anticipated at a valuation of ~$500M based on external investor interest.
Earlier rounds
- February 2026 · seed · $54M
Up against
UltrahumanGabitFITTRAI-powered wearable startups
Words to know
- Secondary share sale
- Existing shareholders sell their shares to new investors; no new money reaches the company.
- ESOP
- Employee Stock Option Plan, a benefit that gives employees the right to buy company shares at a fixed price.
- ESOP buyback
- The company repurchases vested stock options from employees, providing them cash liquidity.
- Entropy (in context of Temple)
- A metric tracked by the wearable that represents the body's metabolic and sympathetic demands.
The numbers around it
Temple has 2 funding rounds in StopDown's archive, $54M raised in all.
| When | Round | Amount | Led by |
|---|---|---|---|
| 28 February 2026 | friends-and-family | $54M | Deepinder Goyal |
| 5 February 2026 | pre-Series A | $3.3 Mn | V3 Ventures |
Healthcare & Life Sciences in July 2026: 11 rounds with a disclosed amount, $87.1 million in all; the biggest was Iswarya (Rs 350 crore). Every sector this year →
Other articles talking about it
Terms in this story
- Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
- Seed round: Pre-seed and seed are the first money a startup raises from outside investors. The difference is how much has been built when the cheque arrives: pre-seed backs an idea or prototype, usually with a cheque under ₹5 crore, while seed backs an early product and runs from a few crore rupees to a few million dollars.
- Valuation: A startup's valuation is the total price investors agree the company is worth, and it decides how many shares their money buys. For young companies it is set by negotiation and comparison, not a formula. In India, pricing rules for foreign investors apply, and angel tax no longer does for money raised since 1 April 2024.
- Secondary sale: A secondary sale is when existing shareholders sell shares to someone else, so the money goes to the sellers and not to the company. It lets founders, early investors and employees get cash without an IPO or acquisition, and gains on unlisted shares held over 24 months are taxed at 12.5%.
Read next
NewsDoctors question Temple wearable's brain-flow claimsTemple makes a ₹85,000 wearable that tracks body signals, including blood flow near the head, and pairs the readings with AI insightsFundingAugust AI raises $12M for US expansionAugust AI offers an AI health assistant that answers medical questions through WhatsApp and a mobile appFundingVitusCare raises $3 million Series BVitusCare runs dialysis units inside partner hospitals, which keeps costs low, and has grown from 22 to over 60 centres
Everything on Temple → · All startup news on 27 July 2026 →
Is this Temple? Get your “Featured on StopDown” badge →